GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Mapk1 | increases phosphorylation | EXP | | 6480464 | CTD | Promegestone results in increased phosphorylation of MAPK1 protein | PMID:16020483 | Mapk1 | multiple interactions | EXP | | 6480464 | CTD | fulvestrant inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] Mifepristone inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | PMID:16020483 | Mapk1 | increases phosphorylation | ISO | RGD:732502 | 6480464 | CTD | Promegestone results in increased phosphorylation of MAPK1 protein | PMID:21258428 | Mapk1 | multiple interactions | ISO | RGD:732502 | 6480464 | CTD | [Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein Gefitinib inhibits the reaction [[Promegestone co-treated with AREG protein] results in increased phosphorylation of MAPK1 protein] Gefitinib inhibits the reaction [Promegestone results in increased phosphorylation of MAPK1 protein] | PMID:21258428 | |
Go Back to source page | Continue to Ontology report |